Marcia Vervloet
Publicatie
Datum
02-12-2024
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE’s key recommendations.
Boven, J.F.M. van, Dima, A.L., Wettermark, B., Potočnjak, I., Ágh, T., Vervloet, M. Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE’s key recommendations. The Lancet Regional Health - Europe: 2025. 48, art. nr. 101164.
Lees online
Introduction
European health systems are under pressure as a result of ageing populations, staff shortages and economic constraints. Therefore, digitalization of care processes, e.g., supporting patients’ medication use, is being increasingly explored.1 The Organisation for Economic Co-operation and Development highlights that poor medication adherence is associated with 200,000 premature deaths and €125 billion of wasted costs in Europe annually, positioning this topic as a key challenge for health system efficiency.2 Digital patient support could be of help here. Notably, the uptake of digital tools to support medication use across Europe was accelerated by the COVID-19 pandemic.3 These digital adherence technologies, such as digital pill dispensers, smart inhalers and electronic blisters, are technically promising and their data may be valuable to inform the European Health Data Space, yet implementation challenges related to privacy and reimbursement persist.
European health systems are under pressure as a result of ageing populations, staff shortages and economic constraints. Therefore, digitalization of care processes, e.g., supporting patients’ medication use, is being increasingly explored.1 The Organisation for Economic Co-operation and Development highlights that poor medication adherence is associated with 200,000 premature deaths and €125 billion of wasted costs in Europe annually, positioning this topic as a key challenge for health system efficiency.2 Digital patient support could be of help here. Notably, the uptake of digital tools to support medication use across Europe was accelerated by the COVID-19 pandemic.3 These digital adherence technologies, such as digital pill dispensers, smart inhalers and electronic blisters, are technically promising and their data may be valuable to inform the European Health Data Space, yet implementation challenges related to privacy and reimbursement persist.
Introduction
European health systems are under pressure as a result of ageing populations, staff shortages and economic constraints. Therefore, digitalization of care processes, e.g., supporting patients’ medication use, is being increasingly explored.1 The Organisation for Economic Co-operation and Development highlights that poor medication adherence is associated with 200,000 premature deaths and €125 billion of wasted costs in Europe annually, positioning this topic as a key challenge for health system efficiency.2 Digital patient support could be of help here. Notably, the uptake of digital tools to support medication use across Europe was accelerated by the COVID-19 pandemic.3 These digital adherence technologies, such as digital pill dispensers, smart inhalers and electronic blisters, are technically promising and their data may be valuable to inform the European Health Data Space, yet implementation challenges related to privacy and reimbursement persist.
European health systems are under pressure as a result of ageing populations, staff shortages and economic constraints. Therefore, digitalization of care processes, e.g., supporting patients’ medication use, is being increasingly explored.1 The Organisation for Economic Co-operation and Development highlights that poor medication adherence is associated with 200,000 premature deaths and €125 billion of wasted costs in Europe annually, positioning this topic as a key challenge for health system efficiency.2 Digital patient support could be of help here. Notably, the uptake of digital tools to support medication use across Europe was accelerated by the COVID-19 pandemic.3 These digital adherence technologies, such as digital pill dispensers, smart inhalers and electronic blisters, are technically promising and their data may be valuable to inform the European Health Data Space, yet implementation challenges related to privacy and reimbursement persist.